Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection

V Sahakian; C P Weiner; S J Naides; R A Williamson; L L Scharosch

doi:10.1016/0002-9378(91)90591-e

Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection

Am J Obstet Gynecol. 1991 Apr;164(4):1090-1. doi: 10.1016/0002-9378(91)90591-e.

Authors

V Sahakian¹, C P Weiner, S J Naides, R A Williamson, L L Scharosch

Affiliation

¹ Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City 52242.

PMID: 1849704
DOI: 10.1016/0002-9378(91)90591-e

Abstract

Congenital human parvovirus B19 infection presented in this case as nonimmune hydrops fetalis that resulted from aplastic anemia at 20 weeks' gestation. Intravascular transfusion therapy led to resolution of the hydrops and a term delivery of an appropriately grown neonate.

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adult
Blood Transfusion, Intrauterine*
Female
Fetal Blood
Hematocrit
Humans
Hydrops Fetalis / microbiology*
Hydrops Fetalis / therapy
Parvoviridae Infections* / microbiology
Pregnancy
Pregnancy Outcome
Ultrasonography, Prenatal

Grants and funding

HD 24494/HD/NICHD NIH HHS/United States